Heparin
- Mucopolysaccharide which is negatively charged, complexes with positively charged plasma proteins.
- Extracted from mast cells of animal tissue.
- 1/2 life is 1 1/2 hours.
- Slows the conversion of prothrombin to thrombin.
- Potentiates the effects of antithrombin III.
- Decreases platelet adhesiveness.
- Monitored by measuring PTT.
- Neutralized with IV protamine sulfate at a dose of 1mg protamine sulfate/100 units of active heparin.
Coumadin (Sodium warfarin)
- Oral dosing
- Inhibits the production of the vitamin K dependent factors II, VII, IX, X.
- May take up to three days to take effect.
- Metabolized by the liver.
- 1/2 life is 36 hours.
- Reversal with IM vitamin K and fresh frozen plasma.
- Monitored by Prothrombin time (PT).
see figure 1
Aspirin
- Inhibits the entire prostaglandin pathway by irreversibly acetylation cyclooxygenase.
- This inhibits prostacyclin and thromboxane production.
- Small doses of aspirin (100 mg/day) selectively inhibit platelet cyclooxygenase more than endothelial cyclooxygenase, with a net effect of decreasing platelet aggregation in response to injury.
see figure 2
Persantine
- Phosphodiesterase inhibitor which acts by inhibiting the breakdown of cAMP within platelets.
- Net result is that there is an increase in platelet cAMP which decrease platelet aggregation.
- When used with aspirin there is an enhanced effect.
Pentoxifylline (Trental)
- Used to treat patients with intermittent claudication.
- Works by altering the rheology of the red blood cell membrane.
- Can increase walking distance 25-40%.
Source:
Vascular Surgery for the House Officer, 2nd edition; Jon R. Cohen